Currently, there are several key IFN-α2b products on the market used in the treatment of several diseases, including melanoma, hairy cell leukemia, non-Hodgkin’s lymphoma, and hepatitis B and C [1]. Here, IFNA2 is linked to hairy cell leukemia.